Radiographic Contrast Agent Nephropathy
Conditions
Keywords
Clinical Decision Support Systems, Contrast-induced nephropathy
Brief summary
The investigators hypothesize that a Clinical Decision Support System (CDSS) designed with Patient-Specific reminders yields superior performance than that with Non-patient-specific reminders in preventing contrast-induced nephropathy.
Detailed description
We hypothesize that a clinical decision support system (CDSS) designed with Patient-specific reminders yields superior performance than that with Non-patient-specific reminders in preventing contrast-induced nephropathy. A 3-arm randomized controlled trial (RCT) will be performed by cluster randomization using physicians as the unit of allocation. Physicians in 3 university medical centers will be randomly assigned into 1) patient-specific arm with Anti Contrast-Induced-Nephropathy(Anti-CIN) reminder, 2) non-patient-specific reminder arm, and 3) the control arm without any reminders, respectively. The patient-specific alert, Anti-CIN system, is designed as a real-time CDSS implementation on CPOE for monitoring physician's contrast-enhanced CT and IVP orders. Computerized pop-up reminders provide the patient-specific encounters with optimal decision options when patients are at a high CIN risk or patients with unknown risk factors are encountered. Non-patient-specific reminders always pop up no matter whether the patient is at a high risk or not.
Interventions
The intervention targets are physicians,not patients. This CDSS alerts physicians only when the patient with high risk of contrast-induced-nephropathy(CIN) is encountered. On the contrast, the CDSS will not alert when the patient without CIN risk is encountered.
The non-patient-specific computerized reminder always pops up to remind physicians to check their patient's CIN risk no matter what CIN risk is.
Sponsors
Study design
Eligibility
Inclusion criteria
* Our intervention targets are physicians but not patients. All physicians working in the hospital may join this trial.
Exclusion criteria
* The physician who never orders a CT scan or IVU study will be excluded * The physician who never operates the CPOE by himself or herself will be excluded
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The percentage of contrast-enhanced imaging(CEI) orders with high CIN risk | Physicains who participated in this trial will be followed for an expected average of 12 months | The number of CEI ordered for patients at high CIN risk, divided by the total number of CEI orders. \[CEI\]: contrast-enhanced image studies,such as CT or IVU. \[CIN\]: contrast-induced nephropathy |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The order elimination rate of high CIN risk orders attributed to the computerized reminder | Physicains who participated in this trial will be followed for an expected average of 12 months | The number of CEI orders with high CIN risk cancelled by the physician attributed to our computerized reminder, divided by the total number of CEI orders with high CIN risk. |
Countries
Taiwan